Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Angie Rizzino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9209-4467; OpenAlex author ID A5062582917; NIH RePORTER profile ID 1863839. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant

Papers 2

  1. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Last author DOI 10.18632/oncotarget.8994↗
  2. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Last author DOI 10.4161/cbt.29182↗

Grants 1

  1. Cancer Biology Training Program T32CA009476↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer D. Black · 1 shared grant, 2024 · strength 0.91
  2. Erin L. Wuebben · 2 shared papers, 2014–2016 · strength 0.12
  3. Jesse L. Cox · 2 shared papers, 2014–2016 · strength 0.12
  4. Michael Anthony Hollingsworth · 2 shared papers, 2014–2016 · strength 0.12
  5. Thomas C. Caffrey · 1 shared paper, 2016 · strength 0.07
  6. Michel M. Ouellette · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.